Ashish Deshmukh to Papillomaviridae
This is a "connection" page, showing publications Ashish Deshmukh has written about Papillomaviridae.
Connection Strength
1.721
-
Human Papillomavirus-Associated Anal Cancer Incidence and Burden Among US Men, According to Sexual Orientation, Human Immunodeficiency Virus Status, and Age. Clin Infect Dis. 2023 Aug 14; 77(3):419-424.
Score: 0.205
-
Prevalence of Human Papillomavirus Infection Among Women Born in the 1990s vs the 1980s and Association With HPV Vaccination in the US. JAMA Health Forum. 2022 08 05; 3(8):e222706.
Score: 0.191
-
Trends in the Incidence of Human Papillomavirus-Associated Cancers by County-Level Income and Smoking Prevalence in the United States, 2000-2018. JNCI Cancer Spectr. 2022 Mar 02; 6(2).
Score: 0.185
-
Comparing Anal Cancer Screening Algorithms Using Cytology and Human Papillomavirus DNA Testing in 3 High-Risk Populations. J Infect Dis. 2021 09 01; 224(5):881-888.
Score: 0.179
-
Incidence Trends and Burden of Human Papillomavirus-Associated Cancers Among Women in the United States, 2001-2017. J Natl Cancer Inst. 2021 06 01; 113(6):792-796.
Score: 0.176
-
Prevalence of high-grade anal dysplasia among women with high-grade lower genital tract dysplasia or cancer: Results of a pilot study. Gynecol Oncol. 2019 05; 153(2):266-270.
Score: 0.150
-
Trends in Risks for Second Primary Cancers Associated With Index Human Papillomavirus-Associated Cancers. JAMA Netw Open. 2018 09 07; 1(5):e181999.
Score: 0.145
-
Two-Year Incidence and Cumulative Risk and Predictors of Anal High-Grade Squamous Intraepithelial Lesions (Anal Precancer) Among Women With Human Immunodeficiency Virus. Clin Infect Dis. 2024 Mar 20; 78(3):681-689.
Score: 0.053
-
International Anal Neoplasia Society's consensus guidelines for anal cancer screening. Int J Cancer. 2024 May 15; 154(10):1694-1702.
Score: 0.053
-
Self-Sampling for Human Papillomavirus Testing: Acceptability in a U.S. Safety Net Health System. Am J Prev Med. 2024 Mar; 66(3):540-547.
Score: 0.052
-
Evaluating the performance of anal cytology and high-risk HPV genotyping for detecting anal HSIL in a clinic-based sample of people living with and without HIV in Puerto Rico. Cancer Cytopathol. 2023 10; 131(10):655-664.
Score: 0.051
-
Perceived barriers to cervical cancer screening and motivators for at-home human papillomavirus self-sampling during the COVID-19 pandemic: Results from a telephone survey. Elife. 2023 05 26; 12.
Score: 0.050
-
Home-based self-sampling vs clinician sampling for anal precancer screening: The Prevent Anal Cancer Self-Swab Study. Int J Cancer. 2023 Aug 15; 153(4):843-853.
Score: 0.050
-
A Cross-Sectional Study of the Prevalence of Anal Dysplasia among Women with High-Grade Cervical, Vaginal, and Vulvar Dysplasia or Cancer: The PANDA Study. Cancer Epidemiol Biomarkers Prev. 2022 12 05; 31(12):2185-2191.
Score: 0.049
-
A systematic review and meta-analysis of cytology and HPV-related biomarkers for anal cancer screening among different risk groups. Int J Cancer. 2022 Dec 01; 151(11):1889-1901.
Score: 0.048
-
Gay and Bisexual Men in the US Lack Basic Information About Anal Cancer. J Low Genit Tract Dis. 2021 Jan 01; 25(1):48-52.
Score: 0.043
-
Mailed self-sample HPV testing kits to improve cervical cancer screening in a safety net health system: protocol for a hybrid effectiveness-implementation randomized controlled trial. Trials. 2020 Oct 21; 21(1):872.
Score: 0.042